Different Persistence of the Cellular Effects Promoted by Protein Kinase CK2 Inhibitors CX-4945 and TDB

We compare the cellular efficacy of two selective and cell permeable inhibitors of the antiapoptotic kinase CK2. One inhibitor, CX-4945, is already in clinical trials as antitumor drug, while the other, TDB, has been recently successfully employed to demonstrate the implication of CK2 in cellular (d...

Descripción completa

Detalles Bibliográficos
Autores principales: Girardi, Cristina, Ottaviani, Daniele, Pinna, Lorenzo A., Ruzzene, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628960/
https://www.ncbi.nlm.nih.gov/pubmed/26558259
http://dx.doi.org/10.1155/2015/185736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628960/
https://www.ncbi.nlm.nih.gov/pubmed/26558259
http://dx.doi.org/10.1155/2015/185736

Ejemplares similares